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Kaposi’s Sarcoma-Associated Herpesvirus Transactivator Rta Induces
Cell Cycle Arrest in G0/G1 Phase by Stabilizing and Promoting
Nuclear Localization of p27kip
Pankaj Kumar, Charles Wood
Nebraska Center for Virology and the School of Biological Sciences, University of Nebraska–Lincoln, Lincoln, Nebraska
The Kaposi’s sarcoma-associated herpesvirus (KSHV) immediate-early gene, replication, and transcription activator (K-
Rta) is a key viral protein that serves as the master regulator for viral lytic replication. In this study, we investigated the
role of K-Rta in cell cycle regulation and found that the expression of K-Rta in doxycycline (Dox)-inducible BJAB cells in-
duced cell cycle arrest in G0/G1 phase. Western blot analysis of key cell cycle regulators revealed that K-Rta-mediated cell
cycle arrest was associated with a decrease in cyclin A and phosphorylated Rb (pS807/pS811) protein levels, both markers
of S phase progression, and an increase in protein levels for p27, a cyclin-dependent kinase inhibitor. Further, we found
that K-Rta does not affect the transcription of p27 but regulates p27 at the posttranslational level by inhibiting its proteo-
somal degradation. Immunofluorescence staining and cell fractionation experiments revealed largely nuclear compart-
mentalization of p27 in K-Rta-expressing cells, demonstrating that K-Rta not only stabilizes p27 but also modulates its
cellular localization. Finally, short hairpin RNA knockdown of p27 significantly abrogates cell cycle arrest in K-Rta-ex-
pressing cells, supporting its key role in K-Rta-mediated cell cycle arrest. Our findings are consistent with previous studies
which showed that expression of immediate-early genes of several herpesviruses, including herpes simplex virus, Epstein-
Barr virus, and cytomegalovirus, results in cell cycle arrest at the G0/G1 phase, possibly to avoid competition for resources
needed for host cell replication during the S phase.
Kaposi’s sarcoma-associated herpesvirus (KSHV), also knownas human herpesvirus-8 (HHV-8), is a member of the gam-
maherpesvirus family, which includes Epstein-Barr virus (EBV),
herpesvirus saimiri (HVS), and murine herpesvirus 68 (MHV 68)
(1). KSHV is the etiological agent of Kaposi’s sarcoma (KS), the
most common tumor associated with HIV infection, and with at
least two other malignancies, pleural effusion lymphoma (PEL)
and multicentric Castleman’s disease (MCD) (2–4). Like all her-
pesviruses, the life cycle of KSHV consists of latent and lytic
phases. The latent phase is characterized by a restricted pattern of
viral gene expression that facilitates the evasion of immune sur-
veillance and the establishment of lifelong persistent infection.
The lytic phase drives the replication cycle, and a majority of the
viral genes are expressed in this phase. This phase mainly allows
for the spread of the virus in the infected individual. A growing
body of research suggests that both latent and lytic replication
phases play an important role in the pathogenesis of KS (5).
The transition from latency to lytic replication is controlled by
the KSHV replication and transcription activator (K-Rta) gene, an
immediately-early (IE) gene carried by open reading frame 50
(ORF50). K-Rta expression has been found to be essential and
sufficient to trigger lytic replication by activating the lytic gene
expression cascade (6–8). Genetic knockout of K-Rta resulted in a
null phenotype in viral DNA synthesis and in virus production
(9). K-Rta is a 691-amino-acid (aa)-long transcriptional factor
that contains an N-terminal DNA-binding domain and a C-ter-
minal activation domain. K-Rta can trigger KSHV lytic reactiva-
tion via transcriptional activation of a number of viral lytic
promoters, by binding either directly to the promoter DNA or
indirectly via interaction with cellular DNA binding proteins
(10–15).
There is a complex interplay between herpesvirus lytic replica-
tion and host cell cycle arrest. Previous studies investigating the
role of cell cycle in herpesvirus lytic replication suggested that host
cell cycle arrest precedes the induction of the lytic cycle and essen-
tially determines whether immediate-early gene expression is ini-
tiated or not (16). However, current research increasingly sup-
ports the idea that cell cycle arrest follows lytic cycle induction and
is a direct consequence of immediate-early gene expression (17–
19). It is hypothesized that arresting cells during early lytic repli-
cation is a common evolutionary strategy employed by herpesvi-
ruses to avoid competition for resources required for viral DNA
replication with the host in the S phase, or it may serve to prevent
premature apoptosis during lytic replication (20). This is in con-
trast to small DNA viruses, especially those lacking their own poly-
merase, like simian virus 40 (SV40) and adenoviruses, which ac-
tively drive host cells into the S phase of the cell cycle in order to
replicate their genome at the same time with host DNA synthesis.
Arresting cell growth early during infection/reactivation may also
be a strategy to avoid being killed by cytotoxic T cells, as it has been
reported that noncycling cells are refractory to killing by cytotoxic
T cells (21).
To date, several herpesvirus-encoded proteins have been iden-
tified that participate in arresting host cell growth. These proteins
are virion components and/or immediate-early transcriptional
factors. For example, the IE product of herpes simplex virus,
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ICPO, has been found to arrest the cell cycle in G1 phase by both
p53-mediated and p53-independent pathways (22, 23). In the case
of EBV, the immediate-early product Zta can induce host cell cycle
arrest by stabilizing p53 and p27 and also through repressing the
expression of c-myc (24, 25). Furthermore, it has been shown that
Zta may cooperate with host transcriptional factor C/EBP to up-
regulate p21, which in turn results in cell cycle arrest (26).
Among the characterized early genes of KSHV, K8, or K-bZIP
protein, a functional homologue of EBV’s immediate-early Zta
protein, was shown to arrest PEL cells in G1 phase during the lytic
cycle by upregulating C/EBP and p21 proteins (27). K8 was also
found to inhibit kinase activities of CDK2 by directly binding
through its bZIP domain (17). However, the role of KSHV-en-
coded ORF50/K-Rta, one of the first genes transcribed and the
central regulator for the initiation of the lytic replication cycle, in
cell cycle regulation has not been evaluated. In the present study,
we demonstrated that K-Rta induces cell cycle arrest in an induc-
ible BJAB cell model, and this growth arrest is mediated by ele-
vated levels of p27, a central cyclin-dependent kinase inhibitor
(CDKI). Our results shed new light on the biological function of
K-Rta as a key cell cycle regulator early during viral reactivation, in
addition to being a transcriptional regulator.
MATERIALS AND METHODS
Cell culture plasmids and transfection. 293T cells, a 293-based doxycy-
cline-inducible K-Rta cell line (TREx293Rta) (provided by Yoshihiro
Izumiya, University of California at Davis, Davis, CA), and Vero cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen,
Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS; Hy-
Clone, Logan, UT) and 100 g/ml penicillin-streptomycin (Mediatech).
DG75 is an EBV-negative Burkitt’s lymphoma (BL)-derived B-cell line
(provided by Luwen Zhang, University of Nebraska-Lincoln, Lincoln,
NE). It was grown in RPMI 1640 medium (Gibco BRL) supplemented
with 10% FBS and 100 g/ml penicillin-streptomycin. TRExBJABRta and
TRExBJAB cells are BJAB (EBV- and KSHV-negative B-cell line)-derived
cell lines with or without the doxycycline-inducible K-Rta gene. They
were provided by Jae Jung (University of Southern California, Los Ange-
les, CA) (28) and were grown in RPMI 1640 medium supplemented with
10% FBS, 100 g/ml penicillin-streptomycin, and 200 g/ml of hygromy-
cin B. KSHV-positive and EBV-negative B-cell lines, BC3 cells (ATCC),
and Cro6 cells (29) (provided by Luwen Zhang, University of Nebraska-
Lincoln, Lincoln, NE) were grown in RPMI 1640 medium (ATCC) sup-
plemented with 20% FBS and 100 g/ml penicillin-streptomycin. Human
microvascular endothelial cells (HMVEC) were grown in endothelial
basal medium-2 (EBM-2) (Lonza, Boston, MA) supplemented with 10%
fetal bovine serum (FBS), 100 g/ml penicillin-streptomycin, 0.01 g/ml
epidermal growth factor, and 1 g/ml hydrocortisone (30). All cultures
were incubated at 37°C with 5% CO2.
K-Rta expression plasmid (pCMVtagORF50), which encodes Flag-
tagged full-length Rta, and pCMVtagORF50(1-527), which encodes trun-
cated K-Rta (amino acids [aa] 1 to 527), were described previously (31).
The transfection of 293T cells and Vero cells was carried out using Lipo-
fectamine 2000 (Invitrogen) or Fugene 6 (Promega) according to the
manufacturer’s recommendations. The transfection of DG75 cells was
carried out using the nucleofection protocol according to the manufac-
turer’s protocols (solution V and program O-006; Amaxa Biosystems).
Cell cycle analysis. Cell cycle profiles were analyzed by flow cytometry
with standard propidium iodide (PI) staining methods (32). Asynchro-
nized and synchronized cells were harvested at the given time points,
washed once with PBS, and fixed in 70% ethanol at 20°C. After collec-
tion of samples from all time points, the cells were washed with PBS twice
and resuspended in PBS containing PI (Roche) at a final concentration of
10 g/ml and RNase A (20 g/ml). The samples were kept at room tem-
perature for 30 min in the dark, and 20,000 events per sample were ac-
quired using a FACSCalibur flow cytometer (BD Biosciences). The data
were analyzed using Modfit LT version 2.0 software (Verity Software
House Inc.).
RNA extraction and RT-PCR. Total cellular RNA was extracted using
an RNeasy kit (Qiagen) according to the manufacturer’s procedures. RNA
samples were digested with DNase (Invitrogen) to remove any residual
DNA. Total RNA (2 g) was used for reverse transcription (RT) using
oligo(dT) as the primers and a Superscript II reverse transcriptase kit
(Invitrogen, Inc., Carlsbad, CA) according to the manufacturer’s instruc-
tions. The primers used for the mRNA quantitation were the following:
p27 (F), 5-CGTCAAACGTAAACAGCTCG-3; p27 (R), 5-CATTCCATG
AAGTCAGCGAT-3; ORF50 (F), 5-CAAACCCCATCCCAACAT-3;
ORF50 (R), 5-AGTAATCACGGCCCCTT-3; glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) (F), 5-CCATGGAGAAGGCTGGGG-3;
and GAPDH (R), 5-CAAAGTTGTCATGGATGACC-3. These target
genes were amplified using the iQ SYBR green real-time master mix (Bio-
Rad) in a Bio-Rad iCyclerIQ thermocycler. All reactions were performed
in triplicate using the following conditions: 50°C for 2 min, 95°C for 10
min, 40 cycles of 95°C for 15 s, and 60°C for 1 min. Melting-curve data for
all of the samples were obtained to ensure specific amplification. All reac-
tions were performed in triplicate and included no-template controls for
each gene. The experiments were repeated 2 times using samples in trip-
licate. Relative gene expression was calculated using the delta delta thresh-
old cycle (CT) method (33). For calculating relative mRNA levels, the
CT value of each gene was normalized to the CT value of GAPDH, and the
normalized CT values from samples were compared to those of the control
samples (untreated).
Immunoprecipitation and immunoblot analysis. Total cell lysates
for immunoprecipitation and Western blotting were prepared in radio-
immunoprecipitation assay buffer (RIPA) (50 mM Tris-HCl [pH 8.0],
150 mM NaCl, 1 mM EDTA, 1% NP-40) supplemented with protease and
phosphatase inhibitor cocktail (Pierce). The lysates were kept on ice for 30
min with occasional vortexing. Finally, the lysates were centrifuged for 15
min at 13,000  g at 4°C and the supernatant was collected. Cytosolic and
nuclear proteins were extracted from TRExBJABRta cells using a Sigma-
CelLytic NuCLEAR extraction kit by using the manufacturer’s protocol.
The protein concentration was measured using a bicinchoninic acid
(BCA) protein kit (Pierce, Rockford, IL). For immunoprecipitation, equal
amounts of lysate from each treatment were precleared with 20 l of
protein A/G Sepharose (1 h, 4°C). Five percent of the precleared lysate was
saved as the input control, and the total amount of p27 was captured by
incubation with 2 g of anti-p27 (SC-1641; Santa Cruz) antibody over-
night at 4°C. Immune complexes were captured with 30 l of a 1:1 mix-
ture of protein A and protein G Sepharose beads (Pierce, Rockford, IL) for
2 h. The beads were then pelleted and washed three times with ice-cold
radioimmunoprecipitation assay (RIPA) buffer. The immunoprecipi-
tated proteins were eluted by heating in 2 sample buffer and subjected to
immunoblotting.
For immunoblotting, equal amounts of total proteins (40 g) were
separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and subsequently transferred to nitrocellulose membranes
using standard methods. After blocking with 5% nonfat dry milk in Tris-
buffered saline (TBS) (20 mM Tris, pH 7.4, 137 mM NaCl) containing
0.01% Tween 20 (TBST) for 1 h, the membrane was incubated with pri-
mary antibody overnight at 4°C. Following washing with TBST three
times, the membrane was incubated with horse peroxidase-conjugated
goat anti-rabbit/mouse secondary antibody (1:10,000; Pierce) or infrared-
tagged secondary antibodies (1:10,000; Licor Inc., Lincoln, NE) for 30
min. Antibody binding was detected using SuperSignal West Dura ex-
tended duration substrate kit (Pierce) or using an Odyssey imager. Image
analysis and quantification of immunoreactive bands was performed us-
ing the Odyssey Infrared Imaging System application software (LiCor
Inc., Lincoln, NE) or NIH ImageJ software.
The following antibodies were used in the present study: anti-rabbit
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K-Rta antibody was a kind gift from Y. Izumiya (UC Davis, CA) and was
used at a dilution of 1:5,000. Anti-rabbit p27 (SC-528), anti-mouse p27
(SC-1641), anti-rabbit p21 (SC-397), anti-rabbit Rb (pS807/pS811)
(BD558389), anti-rabbit cyclin A (SC-751), anti-mouse GAPDH (SC-
32233), anti-mouse ubiquitin (UB) (SC-8017), anti-rabbit Skp2 (H-435),
anti-pp27-T187 (Ab75908), anti-mouse TATA binding protein (Ab818),
and anti-mouse  tubulin (SC-5286) were used at a 1:1,000 dilution in
TBST.
Protein stability test. Exponentially growing TRExBJABRta cells were
cultured in the presence of doxycycline (DOX) for 24 h. DOX-treated and
untreated cells were treated with 50 g/ml cycloheximide (CHX) (Sigma-
Aldrich, St. Louis, MO). The cells were harvested at the indicated time
points after CHX treatment, and cell lysates were subjected to Western
blot analysis. Band intensities were quantitated using Odyssey 3.0 soft-
ware provided with the Odyssey imager (LiCor Inc., Lincoln, NE), and the
half-life of p27 protein was calculated from the slope of the curve.
Immunofluorescence assay. TRExBJABRta cells were treated with
doxycycline for 48 h. The cells were fixed with 4% paraformaldehyde for
20 min, permeabilized with 0.2% Triton X-100 in phosphate-buffered
saline (PBS) for 10 min, and blocked for 30 min with 2% bovine serum
albumin (BSA) in PBS at room temperature. After incubation with pri-
mary antibodies (anti-p27 mouse monoclonal [BD] and anti-rabbit K-
Rta), both at 1:250 dilution in 2% BSA for 2 h at room temperature, the
cells were incubated with anti-mouse Alexa Fluor 488- and anti-rabbit
Alexa Fluor 647-conjugated secondary antibodies (1:1,000) for 1 h at
room temperature. This was followed by three washes with PBS. The last
wash contained 4=,6-diamidino-2-phenylindole (DAPI) (Calbiochem) to
counterstain nuclei. The localization of K-Rta/p27 and DAPI-stained nu-
clei was visualized by confocal microscopy.
Lentivirus-based short hairpin RNA (shRNA) knockdown of p27.
To establish a p27 knockdown cell line, plasmids encoding p27 shRNA (1
and 2) and scrambled negative-control shRNA (1 and 2) were purchased
from Origene and were transfected into TRExBJABRta cells using the
Nucleofector kit T from Lonza (Walkersville, MD) according to the man-
ufacturer’s procedure (program G-016). The transfected cells were se-
lected with puromycin (1 g/ml) for 3 weeks.
Lentivirus vector expressing full-length K-Rta, virus production,
and transduction of HMVEC cells. To generate a lentiviral vector ex-
pressing KSHV full-length Rta, the coding sequence was cloned into
pLVX-AcGFP1 (Clontech). The vesicular stomatitis virus protein G
(VSV-G)-pseudotyped lentiviral particles were produced by transient
cotransfection of 293T cells as described previously (34). Briefly, 5  106
to 6  106 HEK293T cells were cotransfected with 18 g of K-Rta-express-
ing transfer vector (pLVX-Rta), 12 g packaging vector psPAX2, and 6 g
of envelope vector pHEF-VSVG per 10-cm-diameter plate at a 3:2:1 mass
ratio by using a standard calcium phosphate coprecipitation method.
Eight hours posttransfection, the medium was replaced with DMEM sup-
plemented with 10% FBS. The medium containing the virus was har-
vested 48 h posttransfection, filtered through a 0.45-m pore filter, and
concentrated by ultracentrifugation at 4°C for 2 h at 25,000 rpm with a
T-865 rotor (Sorvall). Pellets were gently resuspended in DMEM and kept
overnight at 4°C. The viral titers of concentrated pseudotyped lentiviruses
were determined by transducing 3  105 293T cells seeded in one well of
a 6-well plate in 4 ml of medium containing 8 g/ml of Polybrene
(Sigma). The medium was replaced after 6 h. After 48 h the number of
cells expressing green fluorescent protein (GFP) was determined using
flow cytometry. The viral titers were calculated using the formula (N 
M)/V, where N is the number of target cells used for infection, M is per-
cent GFP-expressing cells, and V is the volume of concentrated virus used
(in ml).
Statistical analysis. All data analysis was done using SPSS software
(v11). Comparison of mean numbers of cells was done using Student’s t
test. All P values of 0.05 were considered significant.
RESULTS
Expression of K-Rta induces cell cycle arrest in G1 phase. Earlier
investigations have reported that tetradecanoyl phorbol acetate
(TPA)-induced reactivation of KSHV results in cell cycle arrest in
G1 phase of the treated cells and implicated the early lytic gene
product K-bZIP for the induction of cell cycle arrest (17). Indeed,
TPA treatment of asynchronously growing BC3 cells (KSHV-pos-
itive latent B-cell line) resulted in a marked increase of cells in the
G1 fraction at 24 h after treatment, from 37 (before treatment) to
56.5%. This increase in proportion of cells arrested in G1 phase
was also noted after TPA treatment of another KSHV-positive
latent B-cell line, Cro6, with a significant increase from 55.6%
(before treatment) to 70.5% at 24 h posttreatment. However,
TPA-induced G1 arrest was not observed in the KSHV negative-
control B-cell line DG75 at 24 h post-TPA treatment (Fig. 1).
These results confirmed previous findings that KSHV lytic reacti-
vation arrests naturally infected B cells in G1 phase.
Since G1 arrest is favored after lytic replication, we sought to
investigate whether any other immediate-early genes besides K-
bZIP was involved in cell cycle arrest. We hypothesized that K-Rta,
being the central regulator of the viral lytic cycle and one of the very
first genes to be transcribed following reactivation, works in concert
with K-bZIP to arrest the cell cycle in G1 phase. To investigate K-Rta’s
role in cell cycle regulation, we utilized TRExBJABRta cells in which
the myc-tagged full-length K-Rta gene is integrated into the chromo-
somal DNA under the control of a tetracycline-inducible pro-
moter. Asynchronously growing exponential-phase cultures of
TRExBJAB (control) and TRExBJABRta were synchronized in
G0/G1 phase by serum starvation. The cells were released from
growth arrest with the addition of medium containing 10%
serum along with doxycycline. We then quantitated the frac-
tion of cells in different phases of the cell cycle by flow cytom-
etry at 24, 48, and 72 h post-Dox treatment for both TRExBJAB
and TRExBJABRta cells. The fraction of cells arrested in G0/G1
phase after 24 h of serum starvation treatment was about 53%
for both cell lines. Serum starvation for an extended time was
avoided, as it affected cell viability. The cell cycle profiles of
both cell lines were similar following release from serum star-
vation without Dox treatment and showed enrichment of cells
in S phase over time (data not shown). Interestingly, the cell
cycle profile clearly showed a significant increase in the number
of cells arrested at G1 phase in TRExBJABRta cells compared to
control TRExBJAB cells at 48 h (P  0.006) and 72 h (P 
0.001) post-Dox treatment (Fig. 2A). In contrast, there were
more cells in S phase for TRExBJAB cells after 48 and 72 h of
Dox treatment, demonstrating that doxycycline alone has little
or no effect on cell cycle progression following the release of
cell cycle arrest in the absence of K-Rta. A significant arrest in
G1 phase was also noted for Dox-treated TREx293Rta cells at 72
h posttreatment compared to untreated cells (P  0.001) (Fig.
2B), further supporting the data observed for BJAB cells. These
results clearly show that the expression of K-Rta alone can
induce cell cycle arrest in G1 phase.
K-Rta expression led to a decrease in phosphorylated Rb and
a parallel increase in p27kip1 protein levels. To explore the un-
derlying mechanism of K-Rta-mediated cell cycle arrest, the ex-
pression kinetics of key cell cycle regulators were analyzed by
Western blotting. Whole-cell lysates were prepared from Dox-
treated and untreated TRExBJAB and TRExBJABRta cells. First,
Kumar and Wood
13228 jvi.asm.org Journal of Virology
we investigated the phosphorylation status of retinoblastoma
(Rb) protein, a critical negative regulator of the cell cycle that
undergoes differential phosphorylation during the cell cycle (35).
In early G1 phase, Rb is largely dephosphorylated and bound to the
E2F family of transcriptional factors, forming a repressor com-
plex. However, upon phosphorylation by Cdk4/6/cyclin D com-
plex during early G1 phase and further by Cdk2/cyclin E during
late G1 phase, Rb dissociates from E2F, activating the expression of
proteins needed for S phase entry and progression (35). We exam-
ined the status of Rb phosphorylation using an antibody that rec-
ognizes Rb phosphorylated at Ser807/Ser811. These sites are the
target sites of Cdk4/6/cyclin D complex during G1 phase. Induc-
tion of K-Rta in TRExBJABRta cells resulted in a significant de-
crease in the phosphorylated levels of Rb, most notably at 48 and
72 h post-Dox treatment (Fig. 3A). The results were markedly
different in Dox-untreated TRExBJABRta cells, which displayed a
significant increase in the levels of phosphorylated Rb in a time-
dependent manner that reached peak expression by 48 h, indicat-
ing that most of these cells were actively progressing through the
cell cycle. In control TRExBJAB cells, the levels of phosphorylated
Rb increased in a time-dependent manner following release from
cell cycle arrest irrespective of Dox treatment, suggesting that Dox
treatment alone did not affect the normal cell cycle progression.
Cyclin A is a useful marker for the S phase, as its expression in-
creases during cell cycle progression (36). Cyclin A expression in
both cell lines, with or without Dox treatment, followed expres-
sion kinetics similar to those of phosphorylated Rb.
Since the activities of G1 cyclin-CDK complexes are mainly
regulated by the Cip/Kip family of cyclin-dependent kinase inhib-
itors (CDKIs), we aimed to evaluate the expression profile of p21
and p27, two central regulators of cell cycle progression that in-
hibit a broad range of cyclin Cdk complexes. The levels of p27
significantly increased over time in Dox-treated TRExBJABRta
cells, but the kinetics of p27 protein accumulation lagged by about
24 h following the expression of Rta in TRExBJABRta cells, reach-
ing maximum levels at 48 h (	5 above background), whereas in
untreated cells, p27 levels decreased in a time-dependent manner.
In TRExBJAB cells, the expression kinetics of p27 was similar in
both Dox-treated and untreated cells and was consistent with
those described for cells entering S phase following cell cycle arrest
in G1 phase. The levels of p21 remained largely unchanged during
the course of the experiment for both cell lines irrespective of Dox
treatment. Since p21 is a direct transcriptional target of p53, we
also investigated the expression levels of p53 and found no signif-
icant change in the relative levels of p53 in both cell lines with or
without Dox treatment (data not shown). These results demon-
strated that K-Rta-mediated cell cycle arrest in BJAB cells does not
involve p21 and is associated with a decrease in Rb phosphoryla-
tion and a parallel increase in p27 levels.
We also examined the expression of p27 in TPA-treated BC3
cells and found that p27 levels increased in a time-dependent
manner following reactivation (Fig. 3B). This increase in p27 lev-
els was not observed in TPA-treated DG75 cells. Although this
increase in p27 levels in TPA-treated BC3 cells does not directly
implicate K-Rta, it does show that cell cycle arrest during reacti-
vation of KSHV from a latently infected B-cell line is associated
with an increase in p27 levels.
To ensure that K-Rta-mediated upregulation of p27 in the
BJAB cell line was not a cell type-specific effect, we transiently
transfected or transduced K-Rta in DG75 cells, Vero cells, and
HMVEC and checked the levels of p27 at 36 h posttransfection/
transduction by Western blotting (Fig. 3C) while the cells were
actively growing at log phase. We found increased levels of p27 in
cells that were transfected or transduced with K-Rta compared to
cells that were transfected/transduced with vector or control virus.
FIG 1 KSHV reactivation following TPA treatment arrests cells in G0/G1 phase. Asynchronously growing exponential-phase cultures of BC3 and Cro6
(KSHV-positive) and DG75 (KSHV-negative) cells were treated with TPA (20 ng/ml). At the indicated times post-TPA treatment, the cells were fixed, stained
with propidium iodide (PI), and analyzed by flow cytometry. Cell cycle phase distribution was determined using ModFit LT version 2.0 software. Cell cycle
profiles presented here are representative of two independent experiments.
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These results suggest that an increase in p27 levels following K-Rta
expression is not unique to BJAB cells.
K-Rta does not affect p27 at the transcriptional level. Since
K-Rta is a transcriptional factor and has the ability to regulate the
expression of cellular genes (37), we investigated the possibility
that the increased level of p27 in K-Rta-expressing cells is due to
transcriptional upregulation of p27 by K-Rta. Real-time PCR was
carried out with RNA samples extracted from Dox-treated and
untreated cells. As shown in Fig. 4A, the level of p27 mRNA after
normalization with GAPDH showed no significant difference be-
fore and after K-Rta induction. The data suggest that the upregu-
lation of p27 in K-Rta-expressing cells is not due to increased p27
mRNA expression. These results were also supported by increased
p27 levels observed in cells transiently transfected with K-Rta lack-
ing the transactivation domain, suggesting that K-Rta does not act
directly on p27 at the transcriptional level or the ability of K-Rta to
upregulate p27 is independent of its transactivation function
(Fig. 4B).
K-Rta expression results in stabilization of p27. Since p27 is
mainly regulated at the posttranslational level via the ubiquitin-
proteasome pathway (38, 39), we examined the effect of K-Rta on
the half-life of p27. Protein synthesis was blocked in K-Rta-ex-
pressing BJAB cells by cycloheximide, and p27 protein levels were
quantitated at various time intervals by immunoblotting (Fig.
5A). As a control, we also monitored p27 levels in TRExBJABRta
cells that were not treated with Dox. In control cells, the half-life of
p27 was found to be approximately 4.1 h, but in K-Rta-expressing
cells the half-life of p27 increased to approximately 7.3 h. The data
suggest that upregulation of p27 in K-Rta-expressing cells most
likely is mediated by changes in protein stability. We next investi-
gated the possibility that reduced polyubiquitination of p27 in
K-Rta-expressing cells is responsible for increased levels of p27.
Polyubiquitination of p27 was assessed by immunoprecipitating
p27 from Dox-treated and untreated TRExBJABRta cells followed
by immunoblotting (Fig. 5B). As expected, there was an increase
in p27 levels in K-Rta-expressing cells in both lysate and immu-
FIG 2 K-Rta arrests cells in G0/G1 phase. (A) Asynchronously growing exponential-phase cultures of the control cell line (TREBJAB) and Rta-inducible BJAB
cell line (TRExBJABRta) were synchronized by serum starvation for 24 h. Growth-arrested cells were stimulated with medium containing 10% serum and
doxycycline (Dox). At the indicated times post-Dox treatment, the cells were fixed, stained with propidium iodide (PI), and analyzed by flow cytometry. Cell cycle
phase distribution was determined using ModFit LT version 2.0 software. Data represent means from three independent experiments. Errors bars represent
standard deviations (SD) for triplicate samples. A significant increase in the number of cells stuck at G0/G1 phase was noted in TRExBJAB versus TRExBJABRta
cells at 48 h (P  0.006) and 72 h (P  0.001) post-Dox treatment. (B) Asynchronously growing exponential-phase cultures of TREx293 Rta cells were treated
with doxycycline. At 72 h post-Dox treatment, treated and untreated cells were fixed and stained with PI, and cell cycle status was determined by flow cytometry
as described above. A significant arrest in G1 phase was noted for Dox-treated TREx293Rta cells at 72 h post-Dox treatment compared to untreated cells (P 
0.001). Cell cycle profiles presented here are means from three independent experiments. Errors bars represent SD for triplicate samples.
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noprecipitate lanes; however, we detected decreased levels of
ubiquitinated p27 in Dox-treated TRExBJABRta cells, as evi-
denced by a reduction of the smear of high-molecular-weight p27
bands compared to those for the uninduced Dox lane. These re-
sults suggest that the expression of K-Rta increases p27 stability by
inhibiting the polyubiquitination and subsequent proteasomal
degradation.
K-Rta promotes nuclear localization of p27. The activity of
p27 is also regulated by its subcellular localization, as it shuttles
between nucleus and cytoplasm during the cell cycle (40). p27 is
exclusively nuclear during G0/G1 phase but is exported to the cy-
toplasm in response to proliferating signals. Since the subcellular
localization of p27 is inherently linked to the regulation of p27
activity, we determined whether K-Rta modulates the subcellular
localization of p27. The localization of endogenous p27 was inves-
tigated in Dox-treated and untreated TRExBJABRta cells by indi-
rect immunofluorescence assay. Figure 6A shows a representative
field of immunostaining. As expected, intense staining, suggest-
ing higher p27 expression levels, was observed in most K-Rta-
expressing cells. Further, the staining for p27 was predomi-
nantly nuclear and colocalized with K-Rta. In most of the
untreated TRExBJABRta cells, the staining for p27 was less intense
and mostly diffuse. In order to confirm the effects of K-Rta on p27
localization observed in the immunofluorescence assay, we per-
formed cell fractionation to determine the levels of p27 in nuclear
and cytosolic extracts of untreated and treated TRExBJABRta cells
by Western blotting (Fig. 6B). We found a significant fraction of
p27 in the nuclear extracts (normalized to the total p27 levels) of
K-Rta-expressing BJAB cells (43% versus 14%) compared to the
control cells. These results demonstrate that in addition to in-
creased stability of p27, modulation of the intracellular localiza-
tion of p27 also occurred in K-Rta-induced G1 arrest.
K-Rta-induced cell cycle arrest coincides with downregula-
tion of Skp2. Multiple degradation pathways that regulate p27
protein levels have been characterized in recent years (39). One of
the best-understood pathways for degradation of p27 is mediated
FIG 3 K-Rta-expressing cells have increased levels of p27kip1. (A) Asynchronously growing exponential-phase cultures of the control cell line (TRExBJAB) and
Rta-inducible BJAB cell line (TRExBJABRta) were synchronized by serum starvation for 24 h. Growth-arrested cells were stimulated with medium containing
10% serum and doxycycline. Doxycycline-treated or untreated TRExBJAB and TRExBJABRta cells were harvested, and the expression kinetics of key cell cycle
regulators were monitored by immunoblotting at the indicated times. GAPDH served as a loading control. The numbers below the p27 band indicate the relative
intensities of the p27 protein normalized to GAPDH protein. (B) Asynchronously growing DG75 (KSHV-negative) and BC3 (KSHV-positive) cells were treated
with TPA (20 ng/ml) for 24 and 48 h. The lysates were immunoblotted with antibodies as indicated. (C) DG75 and Vero cells were transiently transfected with
either empty Flag vector or Flag Rta expression plasmid. Human microvascular endothelial cells (HMVEC) were transduced with equal amounts of either control
lentivirus or lentivirus expressing K-Rta. The cells were harvested after 36 h, and the lysates were immunoblotted with antibodies as indicated. The values below
the figure represent the relative density of p27 bands normalized to that of GAPDH bands.
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by SCF/Skp2 complex in late G1 phase and early S phase (41).
CDK2-dependent phosphorylation at T187 targets p27 to the
SCF/Skp2 complex for ubiquitin-dependent degradation (42).
CDK2-dependent phosphorylation at T187 and binding of phos-
phorylated p27 to Skp2 are both considered rate-limiting steps for
p27 ubiquitination and subsequent degradation (43, 44). We ex-
amined both of these events to better define the mechanism of
K-Rta-mediated upregulation of p27. Figure 7 shows the kinetics
of Spk2 and p27 phosphorylated at T187 from Dox-treated and
untreated TRExBJABRta cells at various time intervals following
release of cell cycle arrest. Skp2 levels decreased over time with
kinetics that parallel the increase in the levels of p27 in K-Rta-
expressing cells. TRExBJABRta cells not treated with Dox had the
opposite kinetics, with gradual accumulation of Skp2 over time.
In K-Rta-expressing cells, there was a decrease in the level of p27
phosphorylation at T187 and a parallel increase in the total p27
levels. However, in cells not treated with Dox, the level of phos-
phorylated p27 at T187 gradually increased over time, with a par-
allel decrease in p27 levels, as expected. These results suggest that
K-Rta-mediated upregulation of p27 is a Skp2-dependent event,
and T187 is the key phosphorylation site targeted.
Knockdown of p27 expression by shRNAs mitigates K-Rta-
induced cell cycle arrest. The data described above strongly sug-
gest that K-Rta-induced cell cycle arrest involved impaired degra-
dation of p27 by Skp2, resulting in accumulation of p27 in the
nucleus. To conclusively prove that the observed accumulation of
p27 had a causal effect on cell cycle arrest or is directly responsible
for K-Rta-mediated cell cycle arrest, we knocked down p27 expres-
sion in the TRExBJABRta cell line by stably expressing shRNAs
against p27. Western blot analysis of Dox-treated TRExBJABRta cell
lines expressing shRNA against p27 showed efficient but incom-
plete knockdown of p27 expression (	80% in both clones 1 and
2) (Fig. 8A). TRExBJABRta cell lines expressing control shRNAs
(clones 1 and 2) showed no significant reduction in levels of p27
compared to the parent TRExBJABRta cell line. We next quanti-
tated cells in G1 phase from TRExBJABRta cells expressing these
shRNAs after release from mitotic arrest and treatment with
Dox. The results from fluorescence-activated cell sorting
(FACS) analysis showed that the downregulation of p27 by
shRNA results in a significant decrease in K-Rta-induced G1
arrest, 	60% of cells in G1 phase compared to 	70% of cells in
G1 phase in parent TRExBJABRta cells or TRExBJABRta cells
FIG 4 K-Rta does not affect p27 at the transcriptional level. (A) RNA was harvested from parallel samples collected at 0, 24, 48, and 72 h from doxycycline-treated
or untreated TRExBJAB and TRExBJABRta cells from the experiment described in the legend to Fig. 2. The samples were subjected to quantitative real-time PCR
analysis to detect the transcript levels of K-Rta, p27, and GAPDH. Each sample was tested in triplicate, and representative data obtained from two independent
experiments are shown. Relative gene expression was normalized to GAPDH expression, and the fold change in the expression of each gene was calculated by
using the CT method. (B) Schematic diagram depicting various domains of Rta protein. 293T cells (5  10
6) were transiently transfected with 4 g of either
empty Flag vector, Flag vector expressing full-length K-Rta (FL), or Flag vector expressing truncated K-Rta (aa 1 to 527). The cells were harvested 36 h
posttransfection, and whole-cell lysate was immunoblotted with anti-Flag antibody, anti-p27 antibody, and anti-GAPDH antibody. LZ, leucine zipper; NLS,
nuclear localization signal.
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stably expressing control shRNAs (Fig. 8B). We did not observe
total abrogation of cell cycle arrest in G1 phase in TRExBJABRta
cells expressing shRNA against p27, but we noticed a significant
decrease of cells in G1 phase compared to TRExBJABRta cells ex-
pressing control shRNA. The data suggest that the accumulation
of p27 observed in K-Rta-expressing cells contributes to cell cycle
arrest in G1.
DISCUSSION
Our study demonstrates that the KSHV immediate-early gene K-
Rta induces cell cycle arrest in G0/G1 phase in an inducible B-cell
line model. Consistent with G1 arrest, K-Rta-mediated cell cycle
arrest was associated with a decrease in the protein levels for cyclin
A and phosphorylated Rb, both markers of S phase progression.
Importantly, our results establish p27, a critical cyclin-dependent
kinase inhibitor (CDKI), as a key player in K-Rta-mediated cell
cycle arrest. The central role of p27 in K-Rta-mediated G1 arrest is
supported by shRNA knockdown of p27, which significantly over-
rode the cell cycle arrest in K-Rta-expressing cells. Since the
knockdown of p27 did not completely abolish K-Rta-mediated G1
arrest, we cannot exclude the possibility that K-Rta also is func-
tioning through other pathways that could contribute to cell cycle
arrest.
Our finding that K-Rta arrests cells in G0/G1 phase is in general
agreement with recent studies that investigated the role of EBV-
encoded Rta (E-Rta) in cell cycle regulation (18). The expression
of inducible E-Rta in 293 and nasopharyngeal carcinoma (NPC)-
derived cells resulted in G1 arrest (18, 19), which was associated
with elevated levels of p21 and p27. However, we did not notice
any significant changes in the expression of p21 in K-Rta-express-
ing cells. It is possible that E-Rta and K-Rta have evolved diverse
mechanisms to arrest the cell cycle in G1 phase, or these diverse
pathways could be due to the different cellular contexts used in the
experiments. It is interesting that the K-Rta-mediated increase in
p27 levels was not at the transcriptional level and was independent
of K-Rta’s transactivation ability. The transactivation function of
several herpesviral immediate-early genes, including Zta, IE2, and
ICP0, was found to be dispensable for cell cycle arrest (25, 45–47).
Instead, the ability to arrest the cell cycle was mapped to key motifs
that are involved in protein-protein interactions, like the bZIP
domain of E-Zta and the RING finger domain for ICP0 (25, 45).
These studies suggest that the transactivation function of imme-
FIG 5 K-Rta affects p27 protein stability. (A) Stability test. K-Rta-inducible BJAB cell cultures (TRExBJABRta) were treated with 50 g/ml cycloheximide (CHX)
in the absence or presence of doxycycline (Dox) for the indicated lengths of time (in hours). Cell lysates were subjected to Western blot analysis with the indicated
antibodies. The relative band intensity of p27 (normalized to GAPDH) was plotted with respect to time after CHX addition. Gel images presented here are
representative of three independent experiments. (B) Doxycycline-treated (for 48 h) and untreated TRExBJABRta cells were pretreated with proteasome
inhibitor MG132 (20 M) before harvesting. Cell extracts were prepared under denaturing lysis conditions, and p27 was immunoprecipitated (IP) from
Dox-treated and untreated TRExBJABRta cells. Immunoprecipitates were subjected to Western blot analysis using p27, Rta, and GAPDH antibody. The same
membrane was stripped and reprobed with anti-ubiquitin (Ub) antibody. Gel images presented here are representative of three independent experiments. WB,
Western blot.
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diate-early genes is less important for mediating cell cycle arrest
than direct interactions with key cell cycle regulators.
In normal cells, p27 levels are maximal in quiescence but fall
rapidly as the cells progress from G1 to S phase. p27 is a short-lived
protein, and its levels are mainly regulated by posttranslational
proteolytic degradation (39, 48). In the late G1 phase, degradation
of p27 is mediated by SCF/Skp2 E3 ubiquitin ligase complex that
requires phosphorylation of p27 at the T187 residue by the cyclin
E,A/CDK2 complex (49). The phosphorylation at T187 creates a
recognition site for Skp2 complex, which induces p27 polyubiq-
uitination and subsequent degradation by the proteasome (41–
43). The data presented here demonstrate that p27 was more sta-
ble in K-Rta-expressing cells. This finding was also supported by
decreased polyubiquitination of p27 observed in K-Rta-express-
ing cells. It is noteworthy that p27 degradation involves both
Skp2-dependent and -independent proteosomal degradation
pathways (39). We have focused on the Skp2-dependent proteo-
somal pathway, as it is the best-characterized and most potent
degradation pathway that determines p27 stability. It remains to
be clarified whether K-Rta-mediated stabilization of p27 also in-
FIG 7 K-Rta-expressing cells have decreased levels of Skp2. TRExBJABRta
cells were serum starved for 24 h. Growth-arrested cells were stimulated with
medium containing 10% serum and doxycycline. At the times indicated, doxy-
cycline-treated and untreated cells were harvested and lysates were subjected
to immunoblot analysis with the indicated antibodies. GAPDH served as a
loading control. Gel images presented here are representative of two indepen-
dent experiments.
FIG 6 K-Rta can promote nuclear localization of p27. (A) TRExBJABRta cells were treated with doxycycline for 48 h. The Dox-treated and untreated cells were
fixed with 4% paraformaldehyde for 20 min, permeabilized with 0.2% Triton X-100 in PBS for 10 min, and blocked for 30 min with 2% bovine serum albumin
(BSA) in PBS. After incubation with primary antibodies (anti-p27 and anti-Rta, both at a 1:250 dilution) in 2% BSA for 2 h at room temperature, the cells were
incubated with anti-mouse Alexa Fluor 488- and anti-rabbit Alexa Fluor 647-conjugated secondary antibodies (1:1,000) for 1 h at room temperature. The Rta and
p27 localization and DAPI-stained nuclei were visualized by confocal microscopy. (B) Cytosolic and nuclear fractions were extracted from TRExBJABRta cells
treated with doxycycline and subjected to Western blotting with the indicated antibodies. TATA binding protein (TBP) and -tubulin were used as a nuclear
fraction and cytosolic fraction loading control, respectively. The bar graph on the right side shows the percentage of p27 quantitated in the nuclear fraction
(normalized to total p27 levels). Gel images presented here are representative of two independent experiments.
Kumar and Wood
13234 jvi.asm.org Journal of Virology
volves another degradation pathway besides the Skp2-dependent
pathway that would function independently of T187 phosphory-
lation.
Based on our results, we hypothesize that there are at least three
nonmutually exclusive possibilities by which K-Rta can induce
cell cycle arrest, as summarized in Fig. 9. First, K-Rta may seques-
ter p27 in the nucleus to prevent its export to the cytoplasm by
direct or indirect interaction. The localization of p27 seems to be
finely regulated during G1 progression (39). To act as a cell cycle
inhibitor, p27 must be localized in the nucleus, whereas its cyto-
plasmic export allows cell cycle progression. In our study, we ob-
served the accumulation of p27 in the nucleus of K-Rta-expressing
cells, but it is difficult to resolve whether K-Rta is directly modu-
lating the subcellular localization of p27 or the nuclear accumula-
tion of p27 is an indirect consequence of K-Rta-mediated cell cycle
arrest. The second possibility is that K-Rta induces or represses the
expression of any upstream kinase or phosphatase that may regu-
late the phosphorylation of p27. Several key phosphorylation sites
have been characterized in recent years, including S10, T157, and
T198, which determine p27 stability and subcellular localization
(39). The third possibility is that K-Rta directly or indirectly in-
teracts with SCF/Skp2 complex to disrupt the binding between
p27 and Skp2, which targets p27 for subsequent proteosomal deg-
radation. Since K-Rta has been shown to possess E3 ubiquitin
ligase activity, the last scenario becomes particularly interesting if
Skp2 is identified as a target for K-Rta-mediated proteosomal deg-
radation (50). In that case, p27 will escape Skp2-mediated proteo-
somal degradation and would accumulate in the nucleus. We were
able to coimmunoprecipitate overexpressed tagged versions of K-
Rta and Skp2 in transiently transfected 293T cells (data not
shown); however, our effort to detect this interaction in vivo under
physiologically relevant conditions was unsuccessful. It is plausi-
FIG 8 Knockdown of p27 expression by shRNAs attenuates K-Rta-induced cell cycle arrest. The parent cell line, TRExBJABRta cells, or TRExBJABRta cells stably
expressing control shRNA (clone 1 and 2) or shRNA against p27 (clone 1 and 2) were serum starved for 24 h. Growth-arrested cells were stimulated with medium
containing 10% serum and doxycycline. At 48 h after doxycycline treatment, the cells were harvested for flow cytometry and immunoblot analysis. (A) Whole-cell
lysates were subjected to immunoblot analysis with the indicated antibodies. GAPDH served as a loading control. The numbers below the p27 band indicate the
relative intensities of the p27 protein normalized to GAPDH protein. (B) For flow cytometry, the cells were fixed and stained with propidium iodide, and cell cycle
phase distribution was determined using ModFit LT version 2.0 software. Data represents the means 
 SD from two independent experiments.
KSHV-Encoded Rta Induces Cell Cycle Arrest
December 2013 Volume 87 Number 24 jvi.asm.org 13235
ble that the interaction between K-Rta and Skp2 is transient in
nature and/or very weak.
Recent research suggests that KSHV lytic reactivation is tightly
linked to B-cell terminal differentiation (51). KSHV remains la-
tent in a not very well-characterized B-cell compartment until B
cells differentiate into plasma cells. This terminal differentiation
provides the physiological lytic switch through plasma cell tran-
scription factor X box binding protein 1 (XBP-1s). Thus, KSHV,
like EBV, reactivates by exploiting the terminal differentiation
pathway of latently infected B cells. In most cell lineages, final
differentiation is associated with loss of proliferation and cell cycle
arrest in G1 phase (52). During the differentiation process, the
expression of various CDKIs, including p27, is upregulated.
Strong evidence for a role of p27 in differentiation programs
comes from studies of mice lacking p27, which show altered dif-
ferentiation programs in various tissues (53–55). It would be in-
teresting to investigate whether K-Rta-mediated upregulation of
p27 following lytic reactivation also plays a role in differentiation
of B cells besides cell cycle arrest.
An issue that remains to be resolved is the experimental
validation of the hypothesis of the presumed benefit of cell
cycle arrest during KSHV or in general herpesvirus lytic repli-
cation. Most studies, including ours, have investigated the role
of herpesviral immediate-early genes in cell cycle regulation in
an overexpressed system. Experimental validation in the con-
text of a normal viral infection setting proves to be a challeng-
ing endeavor, most likely because of the temporal and ephem-
eral nature of cell cycle arrest. In the case of KSHV, it has been
shown that following K-Rta induction there is a substantial
increase in the expression of vCyclin and LANA proteins, both
of which have the potential to accelerate cell cycle progression
by modulating the Rb-E2F pathway. Clearly, more work is
needed to obtain a comprehensive understanding of cell cycle
regulation in herpesvirus lytic replication.
In summary, our results demonstrate that KSHV-encoded
K-Rta is another player besides K8 that participates in arresting
host cells in G1 phase following viral reactivation. K-Rta-me-
diated cell cycle arrest was associated with stabilization and
increased nuclear accumulation of p27. Our study has revealed
a discrete functional role for K-Rta in host cell cycle regulation,
which is independent of its function as a major viral transcrip-
tional factor.
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